Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe and residual-free therapies for animal and human health.
Our lead products, Imilac™ and Milac™, target the main concern in the dairy industry: the management, treatment, and prevention of mastitis in dairy cows.
Mileutis’ technology and products consist of milk-derived peptides and specific protein fragments that have a positive impact on conditions that influence health and reduce antibiotic use in animal health management.
Our novel therapies offer for the first time ever a non-residual, non-antibiotic solution for the biggest health issue of the dairy market. Our leading product line will not only replace antibiotics in the dairy farm but will improve cow wellbeing and provide additional and significant economic value to farmers by increasing milk yield and productivity.
Company Details
- Employees
- 33
- Address
- Golda Meir 7, Ness Ziona,israel 7403650,israel
- in****@****tis.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mileutis.com
- HQ
- Ness Ziona, Israel
Mileutis Ltd. Questions
Mileutis Ltd.'s website is mileutis.com
Mileutis Ltd.'s LinkedIn profile is https://il.linkedin.com/company/mileutis-ltd
Mileutis Ltd. has
33 employees.
View email and phone details for 33
employees at Mileutis Ltd..
Mileutis Ltd.'s industry is
Biotechnology Research
Mileutis Ltd.'s top competitors are
Remilk,
Sol-Gel,
Purple Biotech,
Cognata,
Myrtle Clinical,
Biogiv,
Univo Pharmaceuticals,
Medison Pharma,
Scivac Limited,
Polypid Ltd..
Mileutis Ltd.'s support email address is info@mileutis.com
Mileutis Ltd.'s categories are Biotechnology Research
